Aker BioMarine AS

OB:AKBM Stock Report

Market Cap: NOK 5.8b

Aker BioMarine Valuation

Is AKBM undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AKBM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AKBM (NOK66) is trading below our estimate of fair value (NOK182.84)

Significantly Below Fair Value: AKBM is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AKBM?

Key metric: As AKBM is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AKBM. This is calculated by dividing AKBM's market cap by their current revenue.
What is AKBM's PS Ratio?
PS Ratio1.5x
SalesUS$334.80m
Market CapUS$505.07m

Price to Sales Ratio vs Peers

How does AKBM's PS Ratio compare to its peers?

The above table shows the PS ratio for AKBM vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.1x
GSF Grieg Seafood
0.9x11.0%NOK 6.8b
ISLAX Icelandic Salmon
2.4x11.0%NOK 3.7b
KLDVK Kaldvik
3.7x41.7%NOK 3.6b
MAS Måsøval
1.3x9.4%NOK 3.2b
AKBM Aker BioMarine
1.5x-6.7%NOK 5.8b

Price-To-Sales vs Peers: AKBM is good value based on its Price-To-Sales Ratio (1.5x) compared to the peer average (2.1x).

Price to Sales Ratio vs Industry

How does AKBM's PS Ratio compare vs other companies in the NO Food Industry?

0 CompaniesPrice / SalesEstimated GrowthMarket Cap
No more companies available in this PS range
AKBM 1.5xIndustry Avg. 2.4xNo. of Companies3PS01.22.43.64.86+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AKBM is good value based on its Price-To-Sales Ratio (1.5x) compared to the Norwegian Food industry average (2.5x).

Price to Sales Ratio vs Fair Ratio

What is AKBM's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AKBM PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.5x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: AKBM is expensive based on its Price-To-Sales Ratio (1.5x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AKBM forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentNOK 66.00
NOK 60.25
-8.7%
16.3%NOK 70.06NOK 50.44n/a2
Dec ’25NOK 60.00
NOK 59.90
-0.2%
16.6%NOK 69.86NOK 49.93n/a2
Nov ’25NOK 47.90
NOK 60.11
+25.5%
16.5%NOK 70.05NOK 50.17n/a2
Oct ’25NOK 48.20
NOK 82.77
+71.7%
11.8%NOK 92.51NOK 73.03n/a2
Sep ’25NOK 104.00
NOK 106.67
+2.6%
12.4%NOK 119.94NOK 93.40n/a2
Aug ’25NOK 95.90
NOK 93.47
-2.5%
3.8%NOK 97.02NOK 89.92n/a2
Jul ’25NOK 85.40
NOK 79.07
-7.4%
14.0%NOK 90.17NOK 67.97n/a2
Jun ’25NOK 78.50
NOK 75.83
-3.4%
11.9%NOK 84.85NOK 66.82n/a2
May ’25NOK 70.20
NOK 73.08
+4.1%
3.2%NOK 75.43NOK 70.72n/a2
Apr ’25NOK 64.00
NOK 55.44
-13.4%
8.3%NOK 60.01NOK 50.86n/a2
Mar ’25NOK 54.00
NOK 54.85
+1.6%
9.3%NOK 59.95NOK 49.76n/a2
Feb ’25NOK 45.00
NOK 43.49
-3.4%
3.6%NOK 45.06NOK 41.93n/a2
Jan ’25NOK 46.00
NOK 42.98
-6.6%
4.9%NOK 45.09NOK 40.88n/a2
Dec ’24NOK 40.75
NOK 43.97
+7.9%
2.4%NOK 45.00NOK 42.93NOK 60.002
Nov ’24NOK 39.25
NOK 44.95
+14.5%
0.2%NOK 45.06NOK 44.84NOK 47.902
Oct ’24NOK 39.30
NOK 45.07
+14.7%
0.1%NOK 45.13NOK 45.01NOK 48.202
Sep ’24NOK 45.55
NOK 45.07
-1.1%
0.1%NOK 45.13NOK 45.01NOK 104.002
Aug ’24NOK 41.85
NOK 45.07
+7.7%
0.1%NOK 45.13NOK 45.01NOK 95.902
Jul ’24NOK 34.05
NOK 47.44
+39.3%
5.5%NOK 50.04NOK 44.83NOK 85.402
Jun ’24NOK 35.30
NOK 47.36
+34.2%
5.0%NOK 49.75NOK 44.97NOK 78.502
May ’24NOK 39.95
NOK 44.90
+12.4%
15.3%NOK 51.79NOK 38.02NOK 70.202
Apr ’24NOK 38.85
NOK 43.50
+12.0%
17.1%NOK 50.95NOK 36.04NOK 64.002
Mar ’24NOK 38.80
NOK 42.99
+10.8%
16.3%NOK 50.01NOK 35.98NOK 54.002
Feb ’24NOK 36.00
NOK 45.22
+25.6%
16.0%NOK 52.44NOK 38.00NOK 45.002
Jan ’24NOK 38.05
NOK 47.86
+25.8%
15.8%NOK 55.44NOK 40.28NOK 46.002
Dec ’23NOK 37.30
NOK 47.86
+28.3%
15.8%NOK 55.44NOK 40.28NOK 40.752

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 08:01
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aker BioMarine AS is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Ole-Andreas KrohnDNB Markets
Ola TrovatnDNB Markets